Featured Alzheimer's Disease Posters

In addition to new research presented by Cogstate’s scientific leadership at AAIC 2025, we are proud to highlight additional Alzheimer’s disease research published by our team. See a selection of six featured posters from the hundreds published by our team.

Validation of a Cognitive Safety Monitoring System for Real Time Detection of Central Nervous System Adverse Events in Alzheimer's Disease Clinical Trials

Sensitivity of Individual and Composite Test Scores from the Costate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Validity of a Remote Supervised Preclinical Alzheimer's Disease Cognitive Composite (PACC) Score in Preclinical and Prodromal Alzheimer's Disease

Central Monitoring and Data Quality Assurance: Identifying and Correcting Errors in Category and Letter Fluency Tests in CNS Clinical Trials

Remote Assessment of Cognition with the Unsupervised Version of the Cogstate Brief Battery: Association of Composite Endpoints with Alzheimer's Disease Biomarkers

Equating the ADAS-Cog and MMSE to Cogstate Brief Battery Scores

See our full list of published posters across various CNS indications at the link below.

View All Posters

How can we help you optimize the measurement of brain health?

Contact Our Team
Cogstate
© 2026 Cogstate Ltd.

Cogstate acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the lands where many of our team members live and work. We pay respect to their Elders past and present.